Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 22,694	$ 9,875
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Purchases of investments	(233,698)	(162,411)
Proceeds from disposition of investments	182,336	70,096
Net realized (gain) loss on investments	(992)	(1,056)
Net realized (gain) loss on foreign currency debt	1,474	167
Change in net unrealized (appreciation)/depreciation of investments	807	11,439
Change in net unrealized (appreciation)/depreciation of foreign currency investments	29	1,029
Change in net unrealized (appreciation)/depreciation of foreign currency debt	2	(113)
Net amortization of investment discounts and premiums	(2,344)	(3,066)
Amortization of deferred debt issuance costs	743	711
PIK interest and other income capitalized	(2,896)	(590)
Changes in assets and liabilities:
Decrease (increase) in derivatives, at fair value	181	(221)
Decrease (increase) in receivable for investments sold	(9,684)	(1,908)
Decrease (increase) in interest and other receivables	633	(3,855)
Decrease (increase) in prepaid expenses and other assets	70	268
Increase (decrease) in incentive fees payable	53	421
Increase (decrease) in interest and other debt related payables	(831)	(14)
Increase (decrease) in payable for investments purchased	7,576	(13,883)
Increase (decrease) in management fees payable	136	(74)
Increase (decrease) in accrued expenses and other liabilities	(192)	14
Net cash provided by (used in) operating activities	(33,903)	(93,171)
Financing activities
Proceeds from shares of common stock sold		55,544
Debt borrowings	237,553	172,783
Debt repayments	(183,564)	(123,273)
Distribution paid	(20,774)	(13,398)
Deferred debt issuance costs paid	(7)	(75)
Net cash provided by (used in) financing activities	33,208	91,581
Net increase (decrease) in cash and cash equivalents and restricted cash	(695)	(1,590)
Cash and cash equivalents and restricted cash at beginning of period	1,002	3,293
Cash and cash equivalents and restricted cash at end of period	307	1,703
Supplemental cash flow information
Interest and other debt expenses paid	10,801	9,352
Other financing fees paid		75
Reinvestment of shareholder distributions	$ 5,179	$ 3,010